Skip to main content

About DayOne

We empower healthtech innovation

DayOne is a leading launchpad for high-potential, early-stage ventures at the intersection of healthtech with the life science industry in the Basel Area.

We support ambitious healthtech startups, investors and industry partners in shaping the future of healthcare by accelerating real-world solutions that drive industry transformation.

With a proven track record of success, we provide a high-impact accelerator program, tailored investment opportunities, and an expert-driven support system to help ventures scale, secure strategic partnerships, and achieve long-term growth.

Our mission is to:

  • Empower healthtech startups with the expertise, resources and connections they need to thrive in a complex industry.
  • Bridge the gap between pharma and healthtech startups to drive innovation and create scalable, impactful solutions.
  • Help healthtech investors de-risk opportunities by curating top-tier, market-ready ventures positioned for long-term success.

The challenges we address

80% of healthtech startups fail due to lack of industry access, strategic guidance and funding.

90% of drug development targets fail, with $2.3 billion+ spent per drug and an average 12-year timeline to market.

Global digital health investment is declining, making it harder for startups to secure the support they need.

What we offer

Industry-focused accelerator

A 3-month hybrid program designed to connect healthtech startups with pharma and medtech industry leaders, providing:

  • 1:1 mentorship from senior industry executives
  • Expert-led cohort learning sessions
  • Investor connections and funding pathways
  • Pitch opportunities to pharma and medtech partners

Investment & growth support

Beyond acceleration, we offer long-term strategic support for selected ventures, including:

  • We are building an investment vehicle that will offer curated investment opportunities for startups & investors
  • 2–3-year personalized support programs for select ventures
  • Convertible loans & equity-based funding combined with non-dilutive grants
  • Settling & relocation support in the Basel Area

Global & local impact

  • We scout, select and accelerate the most promising startups in healthtech.
  • We bridge academia, startups and industry through strategic partnerships.
  • We run high-impact industry events.

Our impact at a glance (as of March 2025)

128
ventures supported
64
industry events hosted
13,850
event attendees engaged